MedPath

PrEP (Pre-exposure Prophylaxis) Stigma and Women Ethnodrama Pre-Test Phase

Not Applicable
Completed
Conditions
HIV
Registration Number
NCT06501885
Lead Sponsor
Duke University
Brief Summary

The investigators will develop and pre-test an ethnodrama intervention designed to transform community member beliefs about and foster support of young cisgender women (YCW) using PrEP.

Detailed Description

In Aim 1/Year 1, the investigators will develop the ethnodrama intervention; no data collection activities are included. In Aim 2/Year 2, the investigators will pre-test the ethnodrama intervention with invited groups of young women and members of young women's socio ecology (i.e., male partners, female peers, healthcare providers, informal community leaders, and family members).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
63
Inclusion Criteria
  • 18 years of age or older
  • Young cisgender women who have taken or are taking PrEP
  • Male partners of young women
  • Female peers of young women
  • Healthcare providers
  • Informal community leaders
  • Family members of young women
Exclusion Criteria

None

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Number of participants who find the storylines and interactive components acceptableImmediately post-intervention

The investigators will gather feedback on the acceptability of the storylines (e.g., perceptions of whether the storylines seem real and identifiable) and interactive components (e.g., facilitated discussion).

Secondary Outcome Measures
NameTimeMethod
Potential effectiveness of the intervention's storylines on transforming audience members' PrEP-related perceptions as measured by a brief interviewer-administered survey using the Narrative Transportation Scale (NTS)Immediately post-intervention

The 12-item scale is divided into two sub-scales: engagement and personal connection. Sample items include: "I wanted to learn what happened to the women after the story ended"; "The stories in the dramas are relevant to my everyday life"; and "The stories in the drama are realistic and believable." The total score ranges from 12 to 84, where a higher score indicates greater narrative transportation.

Trial Locations

Locations (1)

Impact Research and Development

🇰🇪

Kisumu, Kenya

Impact Research and Development
🇰🇪Kisumu, Kenya
Jacob Onyango
Contact
jonyango@impact-rdo.org

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.